SAVE-THE-DATE!

 
January 25, 2019

"Recognizing and Supporting "Second Victims":
How Faculty Can Help" - Part 2

  

         

Facilitated by: 

John McPherson, MD, Shannon Skinner, MD and Margaret Burks, MD

Workshop Goals:

• To help medical professionals recognize the negative downstream effects in themselves, peers, and trainees from difficult clinical events

• To help faculty better support trainees through difficult clinical events, including but not limited to a negative patient outcome, near miss, or medical error.

Objectives: (At the end of this session, participants will be able to:)

•  Define a "second victim"

• Specify the negative effects of the "second victim" phenomenon

• List methods found in literature to support a "second victim"

• List characteristics of an effective interaction with a "second victim"

• Create a safe space to support trainees who have experienced a difficult event

• Direct trainees who have experienced a difficult event to the appropriate resources at Vanderbilt

Register and add to calendar

CME Credit:

Sponsored by Vanderbilt University School of Medicine; Office for Health Sciences Education, Office for Continuous Professional Development and the Educator Development Core.

Vanderbilt University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  Vanderbilt School of Medicine designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. It is the policy of the ACCME and Vanderbilt University School of Medicine to require disclosure of financial relationships from individuals in a position to control the content of a CME activity; to identify and resolve conflicts of interest related to those relationships; and to make disclosure information available to the audience prior to the CME activity.  Presenters are required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations.